Discover
CHRS
Coherus Oncology, Inc.
1.47
20 x 1.36
1 x 1.48
bid
ask
+
0.05
3.52%
9 @ 04:00 PM
1.40 -0.07 (4.76%)
| Ytd | 3.52% | |
| 1y | 65.76% |
1.40
day range
1.48
0.81
52 week range
2.62
| Open | 1.43 | Prev Close | 1.42 | Low | 1.40 | High | 1.48 | Mkt Cap | 179.94M |
| Vol | 376.64K | Avg Vol | 1.08M | EPS | -1.26 | P/E | -1.17 | Forward P/E | -5.30 |
| Beta | 0.97 | Short Ratio | 8.43 | Inst. Own | 70.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.52 | 200-d Avg | 1.61 | 1yr Est | 5.90 |
| Income Statement | |||
| Total Revenue | 12.31M | ||
| Revenues (USD) | 12.31M | ||
| Cost of Revenue | 3.81M | ||
| Gross Profit | 8.50M | ||
| Operating Expenses | 44.65M | ||
| Research and Development Expense | 21.54M | ||
| Selling, General and Administrative Expense | 23.10M | ||
| Operating Income | -36.15M | ||
| Interest Expense | 2.19M | ||
| Net Income | -38.33M | ||
| Net Income Common Stock | -38.33M | ||
| Net Income Common Stock (USD) | -38.33M | ||
| Consolidated Income | -38.33M | ||
| Net Income from Discontinued Operations | 1.39M | ||
| Earnings per Basic Share | -0.28 | ||
| Earnings per Basic Share (USD) | -0.28 | ||
| Earnings per Diluted Share | -0.28 | ||
| Earning Before Interest & Taxes (EBIT) | -36.14M | ||
| Earning Before Interest & Taxes (USD) | -36.14M | ||
| Weighted Average Shares | 136.40M | ||
| Weighted Average Shares Diluted | 136.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 115.24M | ||
| Cash and Equivalents (USD) | 115.24M | ||
| Investments | 51.81M | ||
| Investments Current | 51.81M | ||
| Trade and Non-Trade Receivables | 22.51M | ||
| Current Assets | 206.04M | ||
| Property, Plant & Equipment Net | 1.09M | ||
| Total Assets | 266.02M | ||
| Total Debt | 38.10M | ||
| Current Liabilities | 132.33M | ||
| Debt Non-Current | 38.10M | ||
| Total Liabilities | 187.40M | ||
| Accumulated Retained Earnings (Deficit) | -1.42B | ||
| Accumulated Other Comprehensive Income | -268.00K | ||
| Shareholders Equity | 78.62M | ||
| Shareholders Equity (USD) | 78.62M | ||
| Assets Non-Current | 59.99M | ||
| Total Debt (USD) | 38.10M | ||
| Goodwill and Intangible Assets | 45.61M | ||
| Inventory | 14.51M | ||
| Liabilities Non-Current | 55.07M | ||
| Trade and Non-Trade Payables | 73.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 881.00K | ||
| Net Cash Flow from Financing | 53.59M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 26.36M | ||
| Issuance (Purchase) of Equity Shares | 53.65M | ||
| Net Cash Flow from Investing | 30.66M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 31.75M | ||
| Net Cash Flow from Operations | -57.89M | ||
| Share Based Compensation | 2.38M | ||